WHO Considers Ways to Boost Access, Cut Prices for Cancer Drugs

Drug Industry Daily
In a wide-ranging analysis of ways to improve access to cancer drugs, the World Health Organization found the drugs remain costly even in countries with strict drug pricing regulations, price transparency is desirable but won’t really address high prices, and initiatives like value-based pricing may not be all that its advocates promise.

To View This Article:


Subscribe To Drug Industry Daily